Combined Pericapsular Nerve Group (PENG) and Lateral Femoral Cutaneous Nerve (LFCN) Block for Total Hip Arthroplasty: A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Initial pain score
研究概览
简要总结
A clinical trial investigating the effect of a combined locoregional anesthesia technique on the postoperative analgesia outcomes after a total hip arthroplasty. A PENG block will be used in combination with a LFCN block. The results will be compared to a control group that is solely treated with intravenous analgesia. This technique aims to provide improved pain scores after surgery without interference of revalidation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adult patients who underwent a primary total hip replacement under general anesthesia
排除标准
- •insulin dependent diabetes mellitus
- •chronic pain
- •severe dementia or mental retardation
- •allergy to local anesthetics
研究组 & 干预措施
PENG + LFCN block
The participants in this group received a combined regional technique just before surgery:
- Pericapsular nerve group (PENG) block
- Lateral femoral cutaneus nerve (LFCN) block
干预措施: PENG + LFCN block (Procedure)
PENG + LFCN block
The participants in this group received a combined regional technique just before surgery:
- Pericapsular nerve group (PENG) block
- Lateral femoral cutaneus nerve (LFCN) block
干预措施: Ropivacaine injection (Drug)
结局指标
主要结局
Initial pain score
时间窗: 0 hours postoperative
numeric rating score (NRS) of 0 to 10
Pain score after 2h
时间窗: 2 hours postoperative
numeric rating score (NRS) of 0 to 10
Pain score after 24h
时间窗: 24 hours postoperative
numeric rating score (NRS) of 0 to 10
次要结局
- Initial motor function(0 hours postoperative)
- Motor function after 2h(2 hours postoperative)
- Postoperative opioids(24 hours postoperative)
- Intraoperative opioids(intraoperative)
- Motor function after 24h(24 hours postoperative)
研究者
Lennert De Schrijver
Principal Investigator
University Hospital, Antwerp